Health · 10 June 2026

Scientists find why Ozempic fails for some people

Researchers have identified genetic variants that appear to make some people far less responsive to GLP-1 drugs such as Ozempic and Mounjaro. Roughly 10% of the population carries these variants, which seem to cause a form of GLP-1 resistance that blunts the medication's effect. The finding could help doctors predict who will benefit from the drugs before prescribing them.

By BriefTea Editorial · 10 June 2026 at 13:01

Reported by ScienceDaily · How we write briefs

Get the app

More briefs

GeneralGoogle paying £260m to settle UK Play Store developer lawsuit PoliticsJames Cleverly steps down from the shadow cabinet to campaign for London mayor GeneralThe UK Navy just followed four Russian ships again GeneralSarah Ferguson is moving back to the UK following the Epstein scandal GeneralIcelanders vote on restarting EU membership talks after 13 years GeneralGoogle now auto-expands AI answers, pushing links down Browse all stories →